Related Experiment Video
Updated: May 15, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
PET and SPECT in heart failure
Christoph Rischpler1, Stephan Nekolla, Markus Schwaiger
1Department of Nuclear Medicine, Technical University, Munich, Germany. c.rischpler@tum.de
Insights
Nuclear imaging techniques like PET and SPECT offer new insights into heart failure pathophysiology. These methods assess biomarkers for early diagnosis, guiding therapy and monitoring novel cell-based treatments for improved patient outcomes.
Area of Science:
- Cardiology
- Medical Imaging
- Biomarker Discovery
Background:
- Heart failure presents a significant and growing global health challenge with a poor prognosis.
- The underlying physiological mechanisms of heart failure are not yet fully understood.
- While gated CT is used in clinical cardiology, nuclear imaging is advancing.
Purpose of the Study:
- To explore how advanced nuclear imaging techniques provide new insights into heart failure.
- To investigate the potential of these techniques in early diagnosis and therapy guidance.
- To assess their role in monitoring and predicting outcomes for cell-based heart failure therapies.
Main Methods:
- Utilizing Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
- Non-invasively measuring key biomarkers: myocardial blood flow, viability, sympathetic innervation, neoangiogenesis, and matrix metalloproteinases activity.
- Analyzing these biomarkers to understand left ventricle remodeling.
Main Results:
- Nuclear imaging reveals pathophysiological changes in heart failure.
- Biomarker assessment aids in identifying early left ventricle remodeling.
- These techniques show potential for improved diagnosis and intervention.
- Development is underway to monitor cell-based restorative therapies.
Conclusions:
- Advanced nuclear imaging offers novel insights into heart failure.
- Early detection of left ventricle remodeling is possible through biomarker analysis.
- These techniques can guide therapeutic interventions and monitor novel treatments for heart failure.
Abstract:
Heart failure is a serious condition with poor prognosis, which imposes an ever increasing burden on healthcare systems due to its rising prevalence. Nonetheless, physiological processes underlying heart failure remain poorly understood. In recent years, functional imaging such as gated CT has become available for routine clinical cardiology investigations. However, a maturation of nuclear imaging techniques such as PET and SPECT is now yielding new insights into the pathophysiological changes underlying heart failure, based on non-invasive measurements of myocardial blood flow, myocardial viability, sympathetic innervation, neoangiogenesis and matrix metalloproteinases activity. Investigations of these biomarkers have the potential to reveal early aspects of left ventricle remodeling; diagnosis at an earlier stage of heart failure promises to facilitate improved intervention and therapy guidance. Furthermore, nuclear imaging techniques are being developed to monitor and predict outcome of novel cell-based approaches for restorative therapy of heart failure.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
